Creative Medical Technology Files to Offer 3.05M Shares, 6.09M Warrants, Signaling Major Dilution
CELZ is trading near its 52-week low of $1.504 (1.1% above the low).
Summary
Creative Medical Technology Holdings filed to offer up to 3.05 million shares and 6.09 million warrants. This follows an S-1 registration statement filed earlier today for a public offering. The potential share issuance alone represents over 60% dilution based on the company's implied current share count. This capital raise is critical for the company, which reported zero revenue and a $1.48 million cash decrease in Q1 2026, but it comes at a significant cost to existing shareholders. The pricing and final terms of the offering will be crucial to watch.
At the time of this announcement, CELZ was trading at $1.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $1.50 to $6.25. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.